维普中文期刊产品整合服务
6篇 您的检索式:作者名="Elizabeth Lyden"
    题名 作者 年代 出处 被引量
1Poor survival after liver retransplantation: Is hepatitis C to blame?显示文摘Kymberly D.S. Watt Elizabeth R. Lyden Timothy M. McCashland 2003Liver Transplantation2003,,10:1
2Comparison of outcomes of transplantation and resection in patients with early hepatocellular carcinoma: a meta‐analysis显示文摘Mashaal Dhir Elizabeth R. Lyden Lynette M. Smith Chandrakanth Are 2012HPB2012,,9:1
3The time and financial impact of training fellows in endoscopy显示文摘Timothy McCashland Randall Brand Elizabeth Lyden Pat de Garmo 2000The American Journal of Gastroenterology2000,,11:1
4Pancreatic Trauma: A Simplified Management Guideline显示文摘Joe H. Patton Sean P. Lyden Martin A. Croce F. Elizabeth Pritchard Gayle Minard Kenneth A. Kudsk Timothy C. Fabian 1997The Journal of Trauma: Injury, Infection, and Cri1997,,:1
5Comparison of outcomes of transplantation and resection in patients with early hepatocellular carcinoma: a meta‐analysis显示文摘Mashaal Dhir Elizabeth R. Lyden Lynette M. Smith Chandrakanth Are 2012HPB2012,,9:1
6Impact of psychosocial comorbidities on clinical outcomes after liver transplantation: Stratification of a high-risk population显示文摘BACKGROUND Liver transplantation is the accepted standard of care for end-stage liver disease due to a variety of etiologies including decompensated cirrhosis, fulminant hepatic failure, and primary hepatic malignancy. There are currently over 13000 candidates on the liver transplant waiting list emphasizing the importance of rigorous patient selection. There are few studies regarding the impact of additional psychosocial barriers to liver transplant including financial hardship, lack of caregiver support, polysubstance abuse, and issues with medical noncompliance. We hypothesized that patients with certain psychosocial comorbidities experienced worse outcomes after liver transplantation. AIM To assess the impact of certain pre-transplant psychosocial comorbidities on outcomes after liver transplantation. METHODS A retrospective analysis was performed on all adult patients from 2012-2016. Psychosocial comorbidities including documented medical non-compliance, polysubstance abuse, financial issues, and lack of caregiver support were collected. The primary outcome assessed post-transplantation was survival. Secondary outcomes measured included graft failure, episodes of acute rejection, psychiatric decompensation, number of readmissions, presence of infection, recidivism for alcohol and other substances, and documented caregiver support failure.RESULTS For the primary outcome, there were no differences in survival. Patients with a history of psychiatric disease had a higher incidence of psychiatric decompensation after liver transplantation (19% vs 10%, P = 0.013). Treatment of psychiatric disorders resulted in a reduction of the incidence of psychiatric decompensation (21% vs 11%, P = 0.022). Patients with a history of polysubstance abuse in the transplant evaluation had a higher incidence of substance abuse after transplantation (5.8% vs 1.2%, P = 0.05). In this cohort, 15 patients (3.8%) were found to have medical compliance issues in the transplant evaluation. Of these specific patients, 13.3% were found to have substance abuse after transplantation as opposed to 1.3% in patients without documented compliance issues (P = 0.03). CONCLUSION Patients with certain psychosocial comorbidities had worse outcomes following liver transplantation. Further prospective and multi-center studies are warranted to properly determine guidelines for liver transplantation regarding this highrisk population.Neil Bhogal Amaninder Dhaliwal Elizabeth Lyden Fedja Rochling Marco Olivera-Martinez 2019World Journal of Hepatology2019,11,8:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费